ACET – adicet bio, inc. (US:NASDAQ)
Stock Stats
News
Adicet Bio, Inc. (NASDAQ: ACET) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma [Yahoo! Finance]
Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer [Yahoo! Finance]
Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer
Form 8-K Adicet Bio, Inc. For: Dec 19
Form 8-K Adicet Bio, Inc. For: Nov 27
Form 8-K Adicet Bio, Inc. For: Nov 18
Form 8-K Adicet Bio, Inc. For: Nov 08
Form SC 13G/A Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.